Scancell announces positive data from the first stage in its Phase 2 SCOPE trial with SCIB1 cancer vaccine delivered by needle free injection for advanced melanoma

To download click here

Tuesday 19 September 2023 07:00 Categories: News Regulatory News SCIB1 Year - 2023